Status: Not yet recruiting
Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers
This is a small-sample safety study involving 15 healthy volunteers who were divided into groups and underwent 68Ga-ACC-DE, 68Ga-FASN-DE, and 68Ga-ACLY-DE PET/CT imaging for safety, biodistribution, and radiation dosimetry assessments, laying the foundation for subsequent studies on the efficacy of resistance monitoring in melanoma targeted therapy.
Participants needed: 15
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Xijing HospitalUpdated: Aug 11, 2025
Eligibility criteria
Age: 18 to 65 years old (including the boundary values); Gender: Male or female;...
Individuals who cannot tolerate intravenous administration (e.g., those with a h...